Anglikang Plans to Invest 50 Million Yuan in Shengruikang for a 36.47% Stake

Corporate Action
โดย CLS·Read original
Summary · why it matters

Anglikang announced that it plans to invest 50 million yuan of its own funds in three phases to increase capital in Shengruikang Biomedical Hangzhou Company Limited, acquiring a total of 36.4706 percent equity in Shengruikang. After the capital increase is completed, Anglikang will also obtain priority cooperation rights for Shengruikang's research and development products in the Greater China region.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

晟睿康生物医药（杭州）有限责任公司Private▲ Positive
Capitalrelevance

Shengruikang receives 50 million yuan capital injection from Anglikang, valuing the company and providing funds.

© 2026 MarketDXNews